Role of nuclear factor κB in cardiovascular health and disease

Clinical Science

Volumn 118, Issue 10, 2010, Pages 593-605

  Van Der Heiden, Kim ^a   Cuhlmann, Simon ^a   Luong, Le A ^a   Zakkar, Mustafa ^a   Evans, Paul C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Heart failure; Myocardial infarction; Nuclear factor B (NF B); Percutaneous coronary intervention (PCI); Vein grafting

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; DISEASE COURSE; GRAFT DYSFUNCTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHY; HYPOXIA; IMMUNITY; INFLAMMATION; ISCHEMIA; ISCHEMIC PRECONDITIONING; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; STIMULUS; STIMULUS RESPONSE; STRESS; VASCULAR TISSUE; VEIN GRAFT; CARDIOVASCULAR FUNCTION; GENE EXPRESSION REGULATION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 77954036224     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090557     Document Type: Review

References (152)

1. de Winther, M. P. J., Kanters, E., Kraal, G. and Hofker, M. H. (2005) Nuclear factor κB signaling in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 25, 904-914
2. Hoffmann, A., Natoli, G. and Ghosh, G. (2006) Transcriptional regulation via the NF-κB signaling module. Oncogene 25, 6706-6716
3. Sen, R. and Baltimore, D. (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716 (Pubitemid 16020062)
4. Chen, F. E. and Ghosh, G. (1999) Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene 18, 6845-6852
5. Hall, G., Hasday, J. D. and Rogers, T. B. (2006) Regulating the regulator: NF-κB signaling in heart. J. Mol. Cell Cardiol. 41, 580-591
6. Hayden, M. S. and Ghosh, S. (2008) Shared principles in NF-κB signaling. Cell 132, 344-362
7. Wong, E. T. and Tergaonkar, V. (2009) Roles of NF-κB in health and disease: mechanisms and therapeutic potential. Clin. Sci. 116, 451-465
8. Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P.W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W. C., Mak, T.W. et al. (2008) Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378
9. Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. and Chen, Z. J. (2006) Activation of IKK by TNFα requires sitespecific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245-257
10. Chen, Z. J., Bhoj, V. and Seth, R. B. (2006) Ubiquitin, TAK1 and IKK: is there a connection? Cell Death Differ. 13, 687-692
11. Oliver, K. M., Garvey, J. F., Ng, C. T., Veale, D. J., Fearon, U., Cummins, E. P. and Taylor, C. T. (2009) Hypoxia activates NF-κB-dependent gene expression through the canonical signaling pathway. Antioxid. Redox. Signal. 11, 2057-2064
12. Shin, D. H., Li, S. H., Yang, S.W., Lee, B. L., Lee, M. K. and Park, J.W. (2009) Inhibitor of nuclear factor-κB-α derepresses hypoxiainducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1α. FEBS J. 276, 3470-3480
13. Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J. et al. (2006) Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc. Natl. Acad. Sci. U.S.A. 103, 18154-18159
14. Gloire, G., Legrand-Poels, S. and Piette, J. (2006) NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72, 1493-1505
15. Hirotani, S., Otsu, K., Nishida, K., Higuchi, Y., Morita, T., Nakayama, H., Yamaguchi, O., Mano, T., Matsumura, Y., Ueno, H. et al. (2002) Involvement of nuclear factor-κB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105, 509-515
16. Hajra, L., Evans, A. I., Chen, M., Hyduk, S. J., Collins, T. and Cybulsky, M. I. (2000) The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl. Acad. Sci. U.S.A. 97, 9052-9057
17. Lawrence, T., Bebien,M., Liu, G. Y., Nizet, V. and Karin, M. (2005) IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143
18. Hoffmann, A., Levchenko, A., Scott, M. L. and Baltimore, D. (2002) The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298, 1241-1245
19. Nelson, D. E., Ihekwaba, A. E. C., Elliott, M., Johnson, J. R., Gibney, C. A., Foreman, B. E., Nelson, G., See, V., Horton, C. A., Spiller, D. G. et al. (2004) Oscillations in NF-κB signaling control the dynamics of gene expression. Science 306, 704-708
20. Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. S., Bachelerie, F., Thomas, D. and Hay, R. T. (1995) Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15, 2689-2696
21. Krikos, A., Laherty, C. D. and Dixit, V. M. (1992) Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267, 17971-17976
22. Enesa, K., Zakkar, M., Chaudhury, H., Luong, L. A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L. E. and Evans, P. C. (2008) NF-κB suppression by the deubiquitinating enzyme cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 283, 7036-7045
23. Enesa, K., Ito, K., Luong, L. A., Thorbjornsen, I., Phua, C., To, Y., Dean, J., Haskard, D. O., Boyle, J., Adcock, I. et al. (2008) Hydrogen peroxide prolongs nuclear localization of NF-κB in activated cells by suppressing negative regulatory mechanisms. J. Biol. Chem. 283, 18582-18590
24. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-κB puzzle. Cell 109, S81-S96
25. Evans, P. C., Taylor, E. R., Coadwell, J., Heyninck, K., Beyaert, R. and Kilshaw, P. J. (2001) Isolation and characterization of two novel A20-like proteins. Biochem. J. 357, 617-623 (Pubitemid 32735143)
26. Evans, P. C., Smith, T. S., Lai, M. J., Williams, M. G., Burke, D. F., Heyninck, K., Kreike, M. M., Beyaert, R., Blundell, T. L. and Kilshaw, P. J. (2003) A novel type of deubiquitinating enzyme. J. Biol. Chem. 278, 23180-23186
27. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D. and Courtois, G. (2003) The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801-805
28. Evans, P. C., Ovaa, H., Hamon, M., Kilshaw, P. J., Hamm, S., Bauer, S., Ploegh, H. L. and Smith, T. S. (2004) Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem.J. 378, 727-734 (Pubitemid 38406847)
29. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L. et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699
30. Li, Z.W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R. and Karin, M. (1999) The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J. Exp. Med. 189, 1839-1845
31. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170
32. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789
33. Dawn, B., Xuan, Y. T., Marian, M., Flaherty, M. P., Murphree, S. S., Smith, T. L., Bolli, R. and Jones, W. K. (2001) Cardiac-specific abrogation of NF-κB activation in mice by transdominant expression of a mutant IκBα. J. Mol. Cell Cardiol. 33, 161-173
34. Hernandez-Gutierrez, S., Garcia-Pelaez, I., Zentella-Dehesa, A., Ramos-Kuri, M., Hernandez-Franco, P., Hernandez-Sanchez, F. and Rojas, E. (2006) NF-κB signaling blockade by Bay 11-7085 during early cardiac morphogenesis induces alterations of the outflow tract in chicken heart. Apoptosis 11, 1101-1109 (Pubitemid 44035959)
35. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874
36. Cunningham, K. S. and Gotlieb, A. I. (2004) The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest. 85, 9-23
37. Lamon, B. D. and Hajjar, D. P. (2008) Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am. J. Pathol. 173, 1253-1264
38. -/-) fed a fat or a chow diet. Arterioscler. Thromb. Vasc. Biol. 20, 2630-2635
39. Collins, R. G., Velji, R., Guevara, N. V., Hicks, M. J., Chan, L. and Beaudet, A. L. (2000) P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med. 191, 189-194
40. Nakashima, Y., Raines, E.W., Plump, A. S., Breslow, J. L. and Ross, R. (1998) Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18, 842-851
41. Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J. C., Connelly, P. W. and Milstone, D. S. (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107, 1255-1262
42. Tikellis, C., Jandeleit-Dahm, K. A., Sheehy, K., Murphy, A., Chin-Dusting, J., Kling, D., Sebokova, E., Cooper, M. E., Mizrahi, J. and Woollard, K. J. (2008) Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules. Atherosclerosis 199, 55-64
43. Dong, Z. M., Chapman, S. M., Brown, A. A., Frenette, P. S., Hynes, R. O. and Wagner, D. D. (1998) The combined role of P- and E-selectins in atherosclerosis. J. Clin. Invest. 102, 145-152
44. Johnson, R. C., Chapman, S. M., Dong, Z. M., Ordovas, J. M., Mayadas, T. N., Herz, J., Hynes, R. O., Schaefer, E. J. and Wagner, D. D. (1997) Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99, 1037-1043
45. Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P. and Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281 (Pubitemid 128373654)
46. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897
47. Branen, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J. and Jovinge, S. (2004) Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 24, 2137-2142
48. Merhi-Soussi, F., Kwak, B. R., Magne, D., Chadjichristos, C., Berti, M., Pelli, G., James, R. W., Mach, F. and Gabay, C. (2005) Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc. Res. 66, 583-593
49. Monaco, C., Andreakos, E., Kiriakidis, S., Mauri, C., Bicknell, C., Foxwell, B., Cheshire, N., Paleolog, E. and Feldmann, M. (2004) Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 101, 5634-5639
50. Gareus, R., Kotsaki, E., Xanthoulea, S., van der Made, I., Gijbels, M. J. J., Kardakaris, R., Polykratis, A., Kollias, G., de Winther, M. P. J. and Pasparakis, M. (2008) Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis. Cell Metab. 8, 372-383
51. Libby, P., Ridker, P. M. and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143
52. Zandi, E., Chen, Y. and Karin, M. (1998) Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate. Science 281, 1360-1363
53. Molestina, R. E., Miller, R. D., Lentsch, A. B., Ramirez, J. A. and Summersgill, J. T. (2000) Requirement for NF-κB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells. Infect. Immun. 68, 4282-4288
54. Bourcier, T., Sukhova, G. and Libby, P. (1997) The nuclear factor κ-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J. Biol. Chem. 272, 15817-15824
55. Cominacini, L., Pasini, A. F., Garbin, U., Davoli, A., Tosetti, M. L., Campagnola, M., Rigoni, A., Pastorino, A. M., Lo, C., V, C. and Sawamura, T. (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 275, 12633-12638
56. Rodríguez-Ayala, E., Anderstam, B., Suliman, M. E., Seeberger, A., Heimbürger, O., Lindholm, B. and Stenvinkel, P. (2005) Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients. Atherosclerosis 180, 333-340
57. Cosentino, F., Hurlimann, D., Delli, G. C., Chenevard, R., Blau, N., Alp, N. J., Channon, K. M., Eto, M., Lerch, P., Enseleit, F. et al. (2008) Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart 94, 487-492
58. Pierce, G. L., Lesniewski, L. A., Lawson, B. R., Beske, S. D. and Seals, D. R. (2009) Nuclear factor-κB activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 119, 1284-1292
59. Spiecker, M., Peng, H. B. and Liao, J. K. (1997) Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα. J. Biol. Chem. 272, 30969-30974
60. Khan, B. V., Harrison, D. G., Olbrych, M. T., Alexander, R. W. and Medford, R. M. (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 93, 9114-9119
61. Busse, R. and Fleming, I. (1996) Endothelial dysfunction in atherosclerosis. J. Vasc. Res. 33, 181-194
62. Mohan, S., Mohan, N. and Sprague, E. A. (1997) Differential activation of NF-κB in human aortic endothelial cells conditioned to specific flow environments. Am. J. Physiol. 273, C572-C578
63. Henke, N., Schmidt-Ullrich, R., Dechend, R., Park, J. K., Qadri, F., Wellner, M., Obst, M., Gross, V., Dietz, R., Luft, F. C. et al. (2007) Vascular endothelial cell-specific NF-κB suppression attenuates hypertension-induced renal damage. Circ. Res. 101, 268-276
64. Savoia, C. and Schiffrin, E. L. (2007) Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin. Sci. 112, 375-384
65. Hernandez-Presa, M., Bustos, C., Ortego, M., Tunon, J., Renedo, G., Ruiz-Ortega, M. and Egido, J. (1997) Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95, 1532-1541
66. Tham, D. M., Martin-McNulty, B., Wang, Y. X., Wilson, D.W., Vergona, R., Sullivan, M. E., Dole,W. and Rutledge, J. C. (2002) Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs. Physiol. Genomics 11, 21-30
67. Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C. and Ley, K. (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9, 61-67
68. Gawaz, M., Neumann, F. J., Dickfeld, T., Koch, W., Laugwitz, K. L., Adelsberger, H., Langenbrink, K., Page, S., Neumeier, D., Schomig, A. et al. (1998) Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98, 1164-1171
69. Gawaz, M., Page, S., Massberg, S., Nothdurfter, C., Weber, M., Fisher, C., Ungerer, M. and Brand, K. (2002) Transient platelet interaction induces MCP-1 production by endothelial cells via IκB kinase complex activation. Thromb. Haemostasis 88, 307-314
70. Yu, G., Rux, A. H., Ma, P., Bdeir, K. and Sachais, B. S. (2005) Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-κB-dependent manner. Blood 105, 3545-3551
71. Partridge, J., Carlsen, H., Enesa, K., Chaudhury, H., Zakkar, M., Luong, L., Kinderlerer, A., Johns, M., Blomhoff, R., Mason, J. C. et al. (2007) Laminar shear stress acts as a switch to regulate divergent functions of NF-κB in endothelial cells. FASEB J. 21, 3553-3561
72. Geng, Y., Kodama, T. and Hansson, G. K. (1994) Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler. Thromb. 14, 798-806
73. Packard, R. R. S. and Libby, P. (2008) Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 54, 24-38
74. Raines, E. W. and Ferri, N. (2005) Cytokines affecting endothelial and smooth muscle cells in vascular disease. J. Lipid Res. 46, 1081-1092 (Pubitemid 43109823)
75. Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A. and Neumeier, D. (1996) Activated transcription factor nuclear factor-κ B is present in the atherosclerotic lesion. J. Clin. Invest. 97, 1715-1722
76. Zuckerbraun, B. S., McCloskey, C. A., Mahidhara, R. S., Kim, P. K., Taylor, B. S. and Tzeng, E. (2003) Overexpression of mutated IκBα inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation. J. Vasc. Surg. 38, 812-819
77. Kanters, E., Pasparakis, M., Gijbels, M. J., Vergouwe, M. N., Partouns-Hendriks, I., Fijneman, R. J., Clausen, B. E., Forster, I., Kockx, M. M., Rajewsky, K. et al. (2003) Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112, 1176-1185
78. Kanters, E., Gijbels, M. J., van der Made, I, Vergouwe, M. N., Heeringa, P., Kraal, G., Hofker, M. H. and de Winther, M. P. (2004) Hematopoietic NF-κB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 103, 934-940
79. Ritchie, M. E. (1998) Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 98, 1707-1713
80. Newby, A. C. (2008) Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol. 28, 2108-2114
81. Vinten-Johansen, J., Zhao, Z. Q., Jiang, R. and Zatta, A. J. (2005) Myocardial protection in reperfusion with post-conditioning. Expert Rev. Cardiovasc. Ther. 3, 1035-1045
82. Kutala, V. K., Khan, M., Angelos, M. G. and Kuppusamy, P. (2007) Role of oxygen in postischemic myocardial injury. Antioxid. Redox Signalling 9, 1193-1206 (Pubitemid 47080829)
83. Webster, K. A. (2003) Therapeutic angiogenesis: a complex problem requiring a sophisticated approach. Cardiovasc. Toxicol. 3, 283-298
84. Koong, A. C., Chen, E. Y., Mivechi, N. F., Denko, N. C., Stambrook, P. and Giaccia, A. J. (1994) Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54, 5273-5279
85. Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., Sobolewski, A., Condliffe, A. M., Cowburn, A. S., Johnson, N. et al. (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1α- dependent NF-κB activity. J. Exp. Med. 201, 105-115
86. Takada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S. and Aggarwal, B. B. (2003) Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 278, 24233-24241
87. Kamata, H., Manabe, T., Oka, S., Kamata, K. and Hirata, H. (2002) Hydrogen peroxide activates IκB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 519, 231-237
88. Ito, K., Hanazawa, T., Tomita, K., Barnes, P. J. and Adcock, I. M. (2004) Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem. Biophys. Res. Commun. 315, 240-245
89. Weyrich, A. S., Buerke, M., Albertine, K. H. and Lefer, A. M. (1995) Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J. Leukocyte Biol. 57, 45-55
90. Valen, G., Paulsson, G. and Vaage, J. (2001) Induction of inflammatory mediators during reperfusion of the human heart. Ann. Thorac. Surg. 71, 226-232
91. Zingarelli, B., Hake, P. W., Denenberg, A. and Wong, H. R. (2002) Sesquiterpene lactone parthenolide, an inhibitor of IκB kinase complex and nuclear factor-κB, exerts beneficial effects in myocardial reperfusion injury. Shock 17, 127-134
92. Guo, J., Jie, W., Kuang, D., Ni, J., Chen, D., Ao, Q. and Wang, G. (2009) Ischaemia/reperfusion-induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF-κB pathway. Int. J. Exp. Pathol. 90, 355-364
93. Morishita, R., Sugimoto, T., Aoki, M., Kida, I., Tomita, N., Moriguchi, A., Maeda, K., Sawa, Y., Kaneda, Y., Higaki, J. et al. (1997) In vivo transfection of cis element 'decoy' against nuclear factor-κB binding site prevents myocardial infarction. Nat. Med. 3, 894-899
94. Frantz, S., Hu, K., Bayer, B., Gerondakis, S., Strotmann, J., Adamek, A., Ertl, G. and Bauersachs, J. (2006) Absence of NF-κB subunit p50 improves heart failure after myocardial infarction. FASEB J. 20, 1918-1920
95. Misra, A., Haudek, S. B., Knuefermann, P., Vallejo, J. G., Chen, Z. J., Michael, L. H., Sivasubramanian, N., Olson, E. N., Entman, M. L. and Mann, D. L. (2003) Nuclear factor-κB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 108, 3075-3078
96. Murry, C. E., Jennings, R. B. and Reimer, K. A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136
97. Solomon, S. D., Anavekar, N. S., Greaves, S., Rouleau, J. L., Hennekens, C. and Pfeffer, M. A. (2004) Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling. J. Am. Coll. Cardiol. 43, 1511-1514
98. Yellon, D. M., Baxter, G. F., Garcia-Dorado, D., Heusch, G. and Sumeray, M. S. (1998) Ischaemic preconditioning: present position and future directions. Cardiovasc. Res. 37, 21-33
99. Xuan, Y. T., Tang, X. L., Banerjee, S., Takano, H., Li, R. C., Han, H., Qiu, Y., Li, J. J. and Bolli, R. (1999) Nuclear factor-κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ. Res. 84, 1095-1109
100. Morgan, E. N., Boyle, Jr, E. M., Yun, W., Griscavage-Ennis, J. M., Farr, A. L., Canty, Jr, T. G., Pohlman, T. H. and Verrier, E. D. (1999) An essential role for NF-κB in the cardioadaptive response to ischemia. Ann. Thorac. Surg. 68, 377-382
101. Valen, G., Hansson, G. K., Dumitrescu, A. and Vaage, J. (2000) Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFκB and AP-1. Cardiovasc. Res. 47, 49-56
102. Hiasa, G., Hamada, M., Ikeda, S. and Hiwada, K. (2001) Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-κB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. Jpn. Circ. J. 65, 984-990
103. Tahepold, P., Vaage, J., Starkopf, J. and Valen, G. (2003) Hyperoxia elicits myocardial protection through a nuclear factor κB-dependent mechanism in the rat heart. J. Thorac. Cardiovasc. Surg. 125, 650-660
104. Das, D. K., Maulik, N., Sato, M. and Ray, P. S. (1999) Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol. Cell. Biochem. 196, 59-67
105. Lutz, J., Luong, L. A., Strobl, M., Deng, M., Huang, H., Anton, M., Zakkar, M., Enesa, K., Chaudhury, H., Haskard, D. O. et al. (2008) The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J. Mol. Med. 86, 1329-1339
106. Li, H. L., Zhuo, M. L., Wang, D., Wang, A. B., Cai, H., Sun, L.H., Yang,Q., Huang, Y.,Wei, Y. S., Liu, P. P. et al. (2007) Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 115, 1885-1894
107. Souza, H. P., Souza, L. C., Anastacio, V. M., Pereira, A. C., Junqueira, M. L., Krieger, J. E., da Luz, P. L., Augusto, O. and Laurindo, F. R. (2000) Vascular oxidant stress early after balloon injury: evidence for increased NADPH oxidoreductase activity. Free Radical Biol. Med. 28, 1232-1242
108. Cercek, B., Yamashita, M., Dimayuga, P., Zhu, J., Fishbein, M. C., Kaul, S., Shah, P. K., Nilsson, J. and Regnstrom, J. (1997) Nuclear factor-κB activity and arterial response to balloon injury. Atherosclerosis 131, 59-66
109. Jun-Ichi, S., Hiroshi, I., Ryo, G., Ryuichi, M., Kensuke, E. and Mitsuaki, I. (2004) Initial clinical cases of the use of a NF-κB decoy at the site of coronary stenting for the prevention of restenosis. Circ. J. 68, 270-271
110. Egashira, K., Suzuki, J., Ito, H., Aoki, M., Isobe, M. and Morishita, R. (2008) Long-term follow up of initial clinical cases with NF-κB decoy oligodeoxynucleotide transfection at the site of coronary stenting. J. Gene Med. 10, 805-809
111. Suzuki, J., Tezuka, D., Morishita, R. and Isobe, M. (2009) An initial case of suppressed restenosis with nuclear factor-κB decoy transfection after percutaneous coronary intervention. J. Gene Med. 11, 89-91
112. Day, J. R. and Taylor, K. M. (2005) The systemic inflammatory response syndrome and cardiopulmonary bypass. Int. J. Surg. 3, 129-140
113. Asimakopoulos, G. (2001) Systemic inflammation and cardiac surgery: an update. Perfusion 16, 353-360
114. Wan, S., LeClerc, J. L., Antoine, M., DeSmet, J. M., Yim, A. P. and Vincent, J. L. (1999) Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study. Ann. Thorac. Surg. 68, 1230-1235
115. Wan, S., LeClerc, J. L. and Vincent, J. L. (1997) Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112, 676-692 (Pubitemid 27410703)
116. Moat, N. E., Shore, D. F. and Evans, T.W. (1993) Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur. J. Cardiothorac. Surg. 7, 563-573
117. Casey, L. C. (1993) Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann. Thorac. Surg. 56, S92-S96
118. Meldrum, D. R., Partrick, D. A., Cleveland, Jr, J. C., Shenkar, R., Meldrum, K. K., Raiesdana, A., Ayala, A., Brown, J.W. and Harken, A. H. (2003) On-pump coronary artery bypass surgery activates human myocardial NF-κB and increases TNF-α in the heart. J. Surg. Res. 112, 175-179
119. Goebel, U., Siepe, M., Mecklenburg, A., Doenst, T., Beyersdorf, F., Loop, T. and Schlensak, C. (2008) Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation. Eur. J. Cardiothorac. Surg. 34, 1165-1172
120. Liakopoulos, O. J., Schmitto, J. D., Kazmaier, S., Brauer, A., Quintel, M., Schoendube, F. A. and Dorge, H. (2007) Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann. Thorac. Surg. 84, 110-118
121. Duffy, J. Y., McLean, K. M., Lyons, J. M., Czaikowski, A. J., Wagner, C. J. and Pearl, J. M. (2009) Modulation of nuclear factor-κB improves cardiac dysfunction associated with cardiopulmonary bypass and deep hypothermic circulatory arrest. Crit. Care Med. 37, 577-583
122. Kawamura, T., Kadosaki, M., Nara, N., Wei, J., Endo, S. and Inada, K. (2005) Nicorandil attenuates NF-κB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery. Shock 24, 103-108
123. Pearl, J. M., Schwartz, S. M., Nelson, D. P.,Wagner, C. J., Lyons, J. M., Bauer, S. M. and Duffy, J. Y. (2004) Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest. Ann. Thorac. Surg. 77, 994-1000
124. Canver, C. C. (1995) Conduit options in coronary artery bypass surgery. Chest 108, 1150-1155
125. Mitra, A. K., Gangahar, D. M. and Agrawal, D. K. (2006) Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol. Cell Biol. 84, 115-124
126. Shimizu, N., Azuma, N., Nishikawa, T., Hirata, S., Morishita, R., Kaneda, Y. and Sasajima, T. (2007) Effect on vein graft intimal hyperplasia of nuclear factor-κB decoy transfection using the second generation of HVJ vector. J. Cardiovasc. Surg. 48, 463-470
127. Kwei, S., Stavrakis, G., Takahas, M., Taylor, G., Folkman, M. J., Gimbrone, Jr, M. A. and Garcia-Cardena, G. (2004) Early adaptive responses of the vascular wall during venous arterialization in mice. Am. J. Pathol. 164, 81-89
128. Stark, V. K., Hoch, J. R., Warner, T. F. and Hullett, D. A. (1997) Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 17, 1614-1621
129. Motwani, J. G. and Topol, E. J. (1998) Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97, 916-931 (Pubitemid 28113931)
130. Amano, J., Suzuki, A., Sunamori, M., Tsukada, T. and Numano, F. (1991) Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. Am. J. Cardiol. 67, 1234-1236
131. Hoch, J. R., Stark, V. K., Hullett, D. A. and Turnipseed, W. D. (1994) Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 116, 463-470
132. Hoch, J. R., Stark, V.K., van, R. N.,Kim, J. L., Nutt, M. P. and Warner, T. F. (1999) Macrophage depletion alters vein graft intimal hyperplasia. Surgery 126, 428-437
133. Zou, Y., Hu, Y., Mayr, M., Dietrich, H., Wick, G. and Xu, Q. (2000) Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ. Res. 86, 434-440
134. Zhang, L., Peppel, K., Brian, L., Chien, L. and Freedman, N. J. (2004) Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler. Thromb. Vasc. Biol. 24, 2277-2283
135. Zund, G., Dzus, A. L., Pretre, R., Niederhauser, U., Vogt, P. and Turina, M. (1998) Endothelial cell injury in cardiac surgery: salicylate may be protective by reducing expression of endothelial adhesion molecules. Eur. J. Cardiothorac. Surg. 13, 293-297
136. Yoshimura, S., Morishita, R., Hayashi, K., Yamamoto, K., Nakagami, H., Kaneda, Y., Sakai, N. and Ogihara, T. (2001) Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-κB binding site as a novel molecular strategy. Gene Ther. 8, 1635-1642
137. Miyake, T., Aoki, M., Shiraya, S., Tanemoto, K., Ogihara, T., Kaneda, Y. and Morishita, R. (2006) Inhibitory effects of NFκB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J. Mol. Cell Cardiol. 41, 431-440
138. Dorn, G. W. (2007) The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49, 962-970
139. Saito, T. and Giaid, A. (1999) Cyclooxygenase-2 and nuclear factor-κB in myocardium of end stage human heart failure. Congestive Heart Failure 5, 222-227
140. Frantz, S., Fraccarollo, D.,Wagner, H., Behr, T. M., Jung, P., Angermann, C. E., Ertl, G. and Bauersachs, J. (2003) Sustained activation of nuclear factor κB and activator protein 1 in chronic heart failure. Cardiovasc. Res. 57, 749-756
141. Zhou, B., Rao, L., Peng, Y., Wang, Y., Li, Y., Gao, L., Chen, Y., Xue, H., Song, Y., Liao, M. et al. (2009) Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy. BMC Med. Genet. 10, 47
142. Grabellus, F., Levkau, B., Sokoll, A., Welp, H., Schmid, C., Deng, M. C., Takeda, A., Breithardt, G. and Baba, H. A. (2002) Reversible activation of nuclear factor-κB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc. Res. 53, 124-130
143. Kawano, S., Kubota, T., Monden, Y., Kawamura, N., Tsutsui, H., Takeshita, A. and Sunagawa, K. (2005) Blockade of NF-κB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovasc. Res. 67, 689-698
144. Timmers, L., van Keulen, J. K., Hoefer, I. E., Meijs, M. F., van, M. B., den, O. K., van Echteld, C. J., Pasterkamp, G. and de Kleijn, D. P. (2009) Targeted deletion of nuclear factor κB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Circ. Res. 104, 699-706
145. Freund, C., Schmidt-Ullrich, R., Baurand, A., Dunger, S., Schneider, W., Loser, P., El-Jamali, A., Dietz, R., Scheidereit, C. and Bergmann, M.W. (2005) Requirement of nuclear factor-κB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111, 2319-2325
146. Zelarayan, L., Renger, A., Noack, C., Zafiriou, M. P., Gehrke, C., van der Nagel, R., Dietz, R., de, W. L. and Bergmann, M.W. (2009) NF-κB activation is required for adaptive cardiac hypertrophy. Cardiovasc. Res. 84, 416-424
147. Kratsios, P., Huth, M., Temmerman, L., Salimova, E., Al, B. M., Sgoifo, A., Manghi, M., Suzuki, K., Rosenthal, N. and Mourkioti, F. (2010) Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKγ in cardiomyocytes. Circ. Res. 106, 133-144
148. Hikoso, S., Yamaguchi, O., Nakano, Y., Takeda, T., Omiya, S., Mizote, I., Taneike, M., Oka, T., Tamai, T., Oyabu, J. et al. (2009) The IκB kinase β/nuclear factor κB signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ. Res. 105, 70-79
149. Gupta, S., Purcell, N. H., Lin, A. and Sen, S. (2002) Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophy. J. Cell Biol. 159, 1019-1028
150. Li, Y., Ha, T., Gao, X., Kelley, J., Williams, D. L., Browder, I. W., Kao, R. L. and Li, C. (2004) NF-κB activation is required for the development of cardiac hypertrophy in vivo. Am. J. Physiol. Heart Circ. Physiol. 287, H1712-H1720
151. Higuchi, Y., Otsu, K., Nishida, K., Hirotani, S., Nakayama, H., Yamaguchi, O., Matsumura, Y., Ueno, H., Tada, M. and Hori, M. (2002) Involvement of reactive oxygen species-mediated NF-κB activation in TNF-α-induced cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 34, 233-240
152. Cook, S. A., Novikov, M. S., Ahn, Y., Matsui, T. and Rosenzweig, A. (2003) A20 is dynamically regulated in the heart and inhibits the hypertrophic response. Circulation 108, 664-667 (Pubitemid 36999248)